To assess the safety, tolerability and pharmacokinetics of ABT-614 in subjects with type 2
diabetes and chronic kidney disease with albuminuria and to determine whether ABT-614 reduces
glomerular filtration rate.
Drug: Placebo Comparator
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01464320
Ages eligible for Study
19 Years to 70 Years
Genders eligible for Study
Accepts Healthy Volunteers
All locations for NCT01464320
United States (1)
Site Reference ID/Investigator# 63442
Miami, Florida, United States, 33136
View full eligibility
Tris trial is registered with FDA with number: NCT01464320. The sponsor of the trial is Abbott and it is looking for 16 volunteers for the current phase.
Official trial title: A Phase 1b, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single-Dose of ABT-614 and the Effect of ABT-614 on Glomerular Filtration Rate in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Albuminuria
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.